At the global health summit on 21 May, G20 leaders are expected to vote against waiving patents on Covid-19 vaccines, according to draft conclusions seen by Reuters. Instead, the G20 countries will reportedly advocate voluntary sharing of intellectual property rights by pharmaceutical companies.
The debate has been raging in the international community since October 2020, when South Africa and India proposed a patent waiver for Covid-19 vaccines. Discussions are still ongoing at the WTO...